RMI PARTNERS
RMI Partners is a venture company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies. In Eastern Europe and Russia, RMI Partners is one of the largest investors in life sciences. The company makes global investments in a variety of therapeutic areas. RMI Partners is currently managing the venture fund RusnanoMedInvest (RMI, a subsidiary of JSC RUSNANO), which was created in 2012 to develop inn... ovative projects in the field of medicine and pharmaceutics. RMI’s portfolio includes companies from Russia, USA, UK and Israel, specializing in the development and marketing of innovative pharmaceutical and medical technologies, many of which successfully completed an initial public offering (IPO) on NASDAQ, or were purchased by strategic buyers.
RMI PARTNERS
Industry:
Biotechnology Life Science Venture Capital
Founded:
2012-01-01
Status:
Closed
Contact:
+74955453912
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default WordPress Sitelinks Search Box Organization Schema IPv6 Cloudflare WordPress 6.0 Cloudflare Hosting
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-01-08 | Celtaxsys | RMI Partners investment in Series E - Celtaxsys | N/A |
| 2017-04-30 | NovaDigm Therapeutics | RMI Partners investment in Convertible Note - NovaDigm Therapeutics | 150 K USD |
| 2017-04-28 | Epic Sciences | RMI Partners investment in Series D - Epic Sciences | 40 M USD |
| 2017-01-23 | Binx Health | RMI Partners investment in Series D - Binx Health | 35 M USD |
| 2016-06-07 | Clearside Biomedical | RMI Partners investment in Funding Round - Clearside Biomedical | 70 M USD |
| 2015-08-24 | Syndax Pharmaceuticals | RMI Partners investment in Series C - Syndax Pharmaceuticals | 80 M USD |
| 2015-08-01 | Adastra Pharmaceuticals | RMI Partners investment in Series C - Adastra Pharmaceuticals | 4.8 M USD |
| 2015-07-01 | Adastra Pharmaceuticals | RMI Partners investment in Convertible Note - Adastra Pharmaceuticals | 1.32 M USD |
| 2015-06-08 | Celtaxsys | RMI Partners investment in Series D - Celtaxsys | 45 M USD |
| 2015-01-29 | Binx Health | RMI Partners investment in Series C - Binx Health | 20 M USD |